Clarence N AHLEM;James M FRINCKE;Christopher L READING
发明人:
FRINCKE, James M.,READING, Christopher L.,AHLEM, Clarence N.
申请号：
AU2013204371
公开号：
AU2013204371A1
申请日:
2013.04.12
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
#$%^&*AU2013204371A120140123.pdf#####ABSTRACT OF THE DISCLOSURE The invention relates to methods to use 17a-ethynylandrost-5-ene-3p, 7p, 17p-triol to treat ocular diseases or conditions such as dry eye, uveitis or retinitis. The compound can be administered topically to the eye, by 5 intravitreal injection or systemically, e.g., orally. 26
